학술논문

Trastuzumab deruxtecan vs physician's choice in patients with HER2+unresectable and/or metastatic breast cancer previously treated with trastuzumab emtansine: primary results of the randomized, phase 3 study DESTINY-Breast02
Document Type
Journal
Source
CANCER RESEARCH; MAR 1 2023, 83 5, 4p. Supplement: S
Subject
Language
English
ISSN
15387445